Navigation Links
Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy

ept) or placebo (Period B) and time to disease flare and safety were assessed, and an open-label phase designed to assess efficacy and long-term safety (Period C). Children in periods A and B remained on a stable dose of MTX and children in Period C were permitted one of three DMARDs in addition to ORENCIA. Data from Period C will be presented tomorrow. Results from Periods A and B were presented at the of Rheumatology Annual Scientific Meeting in November 2006.

Fifty-nine children randomized to placebo in Period B participated in Period C to receive open label treatment with ORENCIA. Thirty-three of them experienced a flare while 26 did not.

Everyone in Period C received 10 mg/kg of ORENCIA approximately every 28 days. Of the 33 children who received placebo and experienced disease flares during the Period B protocol-mandated withdrawal phase of up to six months, 80 percent had an ACR Pedi 30 response, 70 percent had an ACR Pedi 50 response, 50 percent had an ACR Pedi 70 Response and 27 percent had an ACR Pedi 90 response after re-introduction of therapy with ORENCIA in Period C.

Of the 26 children who received placebo during Period B who did not experience disease flares and then chose to receive open-label ORENCIA treatment during Period C, 76 percent had an ACR Pedi 30 response, 68 percent had an ACR Pedi 50 response, 60 percent had an ACR Pedi 70 Response and 36 percent had an ACR Pedi 90 response after re-introduction of therapy with ORENCIA in Period C.

Of the children who completed Period C, four (6.7 percent) children previously treated with placebo in Period B reported serious adverse events (SAEs) versus five (5.5 percent) children continuously treated with ORENCIA. All SAEs were considered unrelated to ORENCIA according to the investigator. None of these children discontinued due to an adverse event (AE). In addition, no child previously treated with placebo in Period B had an acute infusion reaction during the first infusion
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
3. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
4. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
5. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
6. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
7. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
10. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
11. Investigational Study Evaluates the Effectiveness of Aripiprazole in Adolescents With Schizophrenia
Post Your Comments:
(Date:9/2/2015)... 2, 2015 Advanced Wound Dressings - ... Advanced dressings have steadily replaced traditional bandages and ... of wound indications, such as trauma wounds, burns, ... and physical protection become increasingly critical in wound ... standard therapy. This report focuses on nine ...
(Date:9/2/2015)... Sept. 2, 2015  Array BioPharma Inc. (Nasdaq: ... Executive Officer, Ron Squarer , will present ... Boston.  The public is welcome to participate in ... BioPharma website.Event: Wells Fargo Securities Healthcare ConferencePresenter: Ron ... 2015Time:  , 10:20 a.m. Eastern Time Webcast: ...
(Date:9/2/2015)...   Physicians Rx Pharmacy ("PRxP") today announced ... organization as President and Chief Executive Officer.  ... Chief Executive Officer for Soleo Health Specialty Infusion Services, ... Rx Pharmacy, be responsible for leading the rapidly-growing 340B ... to bring Gaston on as the President and CEO ...
Breaking Medicine Technology:Advanced Wound Dressings - SA Analysis and Market Forecasts 2Gaston L. Bernstein Named President and CEO of Physicians Rx Pharmacy 2
... , LAUSANNE , Switzerland , ... that leverages its unique artificial muscle technology,to restore or improve muscle ... ( $4.5 million ) series A financing. The financing round was ... Capital Romandie (ICR) and Gran Plasa SA. Novartis Venture Funds,were also ...
... 2010 MediSapiens, world,s first,software company for personalized cancer medicine in ... 0.8 million ) seed round,investment from Veraventure, ETFIII advised by Eqvitec Partners, ... , ... VTT Technical Research,Centre of Finland and its collaborators. MediSapiens hosts ...
Cached Medicine Technology:NanoPowers Raises CHF 5 Million ($4.5 Million) in Series A Financing to Support Development of Breakthrough Urinary Incontinence Device 2NanoPowers Raises CHF 5 Million ($4.5 Million) in Series A Financing to Support Development of Breakthrough Urinary Incontinence Device 3MediSapiens Gets $ 1 Million for World's First Personalized Cancer Medicine Software 2MediSapiens Gets $ 1 Million for World's First Personalized Cancer Medicine Software 3MediSapiens Gets $ 1 Million for World's First Personalized Cancer Medicine Software 4
(Date:9/2/2015)... Los Angeles, CA (PRWEB) , ... September 02, 2015 , ... According to an ... law by California Governor Jerry Brown that aims to do away with grand juries in ... line of duty. Passed as a direct response to grand jury decisions in Ferguson and ...
(Date:9/2/2015)... ... September 02, 2015 , ... Specifically, VOI Consulting ... recently following a decision by the Centers for Medicare & Medicaid Services (CMS) ... approximately $71,000 or roughly 40% of its headline-grabbing $178,000 price tag. , ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... today the launch of its enhanced, cloud-based mobile ePrescribing application. The release of ... on improving prescriber usability. A leader in health technology, RxNT was one of ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... intermediate or final products. Automating sample handling makes density measurements more efficient and ... each step of the automated workflow and the advantages compared to manual sample ...
(Date:9/2/2015)... ... September 02, 2015 , ... A UPMC and University ... international recognition as a premier center for treatment of and research into hereditary ... bleeding and stroke. , Cure HHT, previously known as The HHT Foundation ...
Breaking Medicine News(10 mins):Health News:Article on Recent Grand Jury Law Brings Increased Accountability to Wrongful Death Cases, says the Law Offices of Burg & Brock 2Health News:Article on Recent Grand Jury Law Brings Increased Accountability to Wrongful Death Cases, says the Law Offices of Burg & Brock 3Health News:Analysis Shows Amgen’s Leukemia Drug, Blincyto, Will Cost 60% Less than Highly Publicized $178,000 Price Tag 2Health News:Analysis Shows Amgen’s Leukemia Drug, Blincyto, Will Cost 60% Less than Highly Publicized $178,000 Price Tag 3Health News:Analysis Shows Amgen’s Leukemia Drug, Blincyto, Will Cost 60% Less than Highly Publicized $178,000 Price Tag 4Health News:RxNT Releases Enhanced ePrescribing iPhone App to Improve Prescriber Usability 2Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 2Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 3Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 2Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 3Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 4
... that yoga therapy can reduce risk factors and improve the ... improve physical, psychological and spiritual //health - or so it ... reviewed the best evidence they could find on the effects ... out of 11 - trials that were good enough to ...
... An extract of grape seed heals wounds by helping new ... free radicals in the damaged area.// Researchers at Ohio State ... on wound healing. They looked at how an extract of ... in experimental animals. ,The extract had a dynamic ...
... tool to the field of medicine. An interactive video ... treatment. The days when doctors told you what treatment ... participate in the decision-making process. But sometimes this is ... new research comes up all the time. ...
... There has always been an ongoing argument regarding the do's ... retreat suggest a new and better way through the dieting ... latest fashion being the 'low carb' approach - for many ... experts at the 'no diet' women's retreat Green Mountain in ...
... better than conventional treatment for managing asthma attacks. ... immune cells known eosinophils increase// in the airways. ... how targeting this build up of eosinophils in ... asthma attack. ,The conventional treatment consists ...
... study that people who have felt psychologically low or under ... expected.// Undergraduate students in the UK all get a vaccination ... potentially fatal brain infection. So they form an ideal population ... ,Researchers at the University of Birmingham asked a group ...
Cached Medicine News:
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: